<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="new antibiotic (38). In 2019 an estimation performed by the" exact="Centers for Disease Control and Prevention" post="(CDC) in the United States reported that more than"/>
 <result pre="of N. gonorrhoeae to rapidly acquire resistance has led the" exact="World Health Organization" post="and Center for Disease Control (US) to classify this"/>
 <result pre="of University of Bologna (IT). This work was sponsored by" exact="GlaxoSmithKline" post="Biologicals SA. The authors wish to thank Giorgio Corsi"/>
 <result pre="editorial assistance. Funding. This work has received funding under the" exact="European Research Council" post="(ERC) advanced grant agreement number 787552 (vAMRes). References References"/>
 <result pre="10.1128/AAC.01586-1830617096 38.collab: World Health OrganizationPrioritization of Pathogens to Guide Discovery," exact="Research and Development" post="of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis."/>
 <result pre="39.collab: CDCAntibiotic Resistance Threats in the United States. Atlanta, GA:" exact="Department of Health" post="and Human Services, CDC (2019). 40.MichalopoulosAFalagasMETreatment of acinetobacter infections."/>
</results>
